The editor's roundtable: chronic stable angina pectoris.
Friedewald
Vincent E
VE
Department of Internal Medicine, The University of Texas Medical School at Houston, Houston, Texas, USA. vfriedew@nd.edu
King
Spencer B
SB
Pepine
Carl J
CJ
Vetrovec
George W
GW
Roberts
William C
WC
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000787:Angina Pectoris / Q000503:physiopathology* / Q000628:therapy*; D015906:Angioplasty, Balloon, Coronary; D001241:Aspirin / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002908:Chronic Disease; D005260:Female; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D010975:Platelet Aggregation Inhibitors; D014665:Vasodilator Agents; D001241:Aspirin